Screener
Evolent Health, Inc. EVH EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Evolent Health, Inc.’s reported figures.
The source filing: Evolent Health, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:53 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628908-26-000086
FAQ
- What is Evolent Health, Inc.'s EBITDA?
- Evolent Health, Inc. (EVH) reported EBITDA of $12.01M in Q2 2026.
- How has Evolent Health, Inc.'s EBITDA changed year-over-year?
- Evolent Health, Inc.'s EBITDA decreased by 45.4% year-over-year, from $21.97M to $12.01M.
- What is the long-term trend for Evolent Health, Inc.'s EBITDA?
- Over 4 years (2021 to 2025), Evolent Health, Inc.'s EBITDA has grown at a 102.1% compound annual growth rate (CAGR), from $17.63M to -$294.29M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Evolent Health, Inc.'s ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude